TGFB1 and Miyoshi myopathy: While the exact causes for the lack of durable responses in CAR T-cell therapy for the treatment of MM have not been determined, the elevated concentration of TGF-β, a highly potent immunosuppressive cytokine, in BM where MM cells localize has to be considered as a contributing factor.